Huntsman Carole

Track

Insider profile

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 43% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Huntsman Carole's trades of Madrigal Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-06 2026-03-06
S Sale
2,824 +16.8%
313.97
US$928,483 		2,824 +16.8% 313.97 US$928,483
2026-03-06 2026-03-06
PrS Proposed sale
29,630
167.41
US$2,687,159 		29,630 167.41 US$2,687,159
2026-01-26 2026-01-26
PrS Proposed sale
24,930
23.83
US$3,064,194 		24,930 23.83 US$3,064,194
2026-01-26 2026-01-26
PrS Proposed sale
340
480.45
US$163,353 		340 480.45 US$163,353
2026-01-26 2026-01-26
PlS Planned sale
570 -5.9%
494.59
US$281,916 		570 -5.9% 494.59 US$281,916
2026-01-26 2026-01-26
S Sale
340 -3.4%
492.42
US$167,423 		340 -3.4% 492.42 US$167,423
2025-11-21 2025-11-21
PrS Proposed sale
1,064
542.12
US$576,816 		1,064 542.12 US$576,816
2025-11-21 2025-11-21
PrS Proposed sale
894
542.12
US$484,655 		894 542.12 US$484,655
2025-11-21 2025-11-21
PlS Planned sale
80 -0.8%
564.57
US$45,165 		80 -0.8% 564.57 US$45,165
2025-11-21 2025-11-21
PlS Planned sale
40 -0.4%
563.21
US$22,528 		40 -0.4% 563.21 US$22,528
2025-11-21 2025-11-21
PlS Planned sale
80 -0.8%
560.62
US$44,850 		80 -0.8% 560.62 US$44,850
2025-11-21 2025-11-21
PlS Planned sale
200 -1.9%
559.60
US$111,920 		200 -1.9% 559.60 US$111,920
2025-11-21 2025-11-21
PlS Planned sale
120 -1.1%
556.04
US$66,725 		120 -1.1% 556.04 US$66,725
2025-11-21 2025-11-21
PlS Planned sale
40 -0.4%
553.23
US$22,129 		40 -0.4% 553.23 US$22,129
2025-11-21 2025-11-21
PlS Planned sale
200 -1.9%
552.38
US$110,477 		200 -1.9% 552.38 US$110,477
2025-11-21 2025-11-21
PlS Planned sale
40 -0.4%
549.34
US$21,974 		40 -0.4% 549.34 US$21,974
2025-11-21 2025-11-21
PlS Planned sale
120 -1.1%
548.71
US$65,845 		120 -1.1% 548.71 US$65,845
2025-11-21 2025-11-21
PlS Planned sale
144 -1.3%
547.27
US$78,807 		144 -1.3% 547.27 US$78,807
2025-11-21 2025-11-21
S Sale
894 -7.5%
550.97
US$492,567 		894 -7.5% 550.97 US$492,567
2025-03-05 2025-03-03
PlS Planned sale
563 -6.1%
335.00
US$188,605 		563 -6.1% 335.00 US$188,605
2025-03-05 2025-03-03
PlS Planned sale
100 -1.1%
329.64
US$32,964 		100 -1.1% 329.64 US$32,964
2025-03-05 2025-03-03
PlS Planned sale
100 -1.1%
327.49
US$32,749 		100 -1.1% 327.49 US$32,749
2025-03-05 2025-03-03
PlS Planned sale
100 -1.1%
326.34
US$32,634 		100 -1.1% 326.34 US$32,634
2025-03-05 2025-03-03
PlS Planned sale
200 -2.1%
324.59
US$64,918 		200 -2.1% 324.59 US$64,918
2025-03-05 2025-03-03
PlS Planned sale
200 -2.0%
323.65
US$64,730 		200 -2.0% 323.65 US$64,730
2025-03-05 2025-03-03
PlS Planned sale
300 -3.0%
320.21
US$96,063 		300 -3.0% 320.21 US$96,063
2025-03-05 2025-03-03
PlS Planned sale
200 -1.9%
314.74
US$62,948 		200 -1.9% 314.74 US$62,948
2025-03-05 2025-03-03
PlS Planned sale
71 -0.7%
313.08
US$22,229 		71 -0.7% 313.08 US$22,229
2025-03-03 2025-03-03
PrS Proposed sale
1,834
341.27
US$625,889 		1,834 341.27 US$625,889
2025-01-27 2025-01-24
S Sale
347 -3.2%
335.24
US$116,328 		347 -3.2% 335.24 US$116,328
2025-01-24 2025-01-24
PrS Proposed sale
347
340.14
US$118,029 		347 340.14 US$118,029
2024-11-22 2024-11-21
S Sale
688 -6.0%
316.92
US$218,041 		688 -6.0% 316.92 US$218,041
2024-11-21 2024-11-21
PrS Proposed sale
688
316.92
US$218,040 		688 316.92 US$218,040